45 CFR § 180 compliance
F · 55
This hospital published little of what § 180 requires.
●Machine-readable file published
○Gross / standard charges
○Discounted cash price
●Payer-specific negotiated rates
○Min / max negotiated charges
●Free, public, no login required
Procedures listed
13,855
Insurances with rates
1
CPT / HCPCS codes
12,237
Source MRF
Most expensive procedures (gross)
| Code | Description | Gross | Cash | Min payer | Max payer | # insurers |
|---|---|---|---|---|---|---|
| J3399 | Onasemnogene Abeparvovec-xioi 2x8.3 ML Susp Kit | $2,337,500 | $1,870,000 | — | — | 3 |
| J1823 | Inebilizumab-cdon IV Soln 100 MG/10ML (10 MG/ML) | $163,900 | $131,120 | — | — | 9 |
| 0811 | LIVE DONOR KIDNEY ACQUIS | $83,376 | $66,701 | — | — | 2 |
| 0812 | KIDNEY STANDARD ACQUIS | $83,376 | $66,701 | — | — | 2 |
| J7330 | ALLO CARTICEL IMPLT GENZ*NLU* | $79,963 | $63,970 | — | — | 2 |
| J2326 | Nusinersen Intrathecal Soln 12 MG/5ML (2.4 MG/ML) | $79,838 | $63,870 | — | — | 3 |
| J9269 | Tagraxofusp-erzs IV Soln 1000 MCG/ML | $73,540 | $58,832 | — | — | 3 |
| J9226 | Histrelin Acetate (CPP) Implant Kit 50 MG | $73,301 | $58,641 | — | — | 3 |
| C1735 | CATH RDN SYMPLICITY SPYRAL 4FR | $70,500 | $56,400 | — | — | 2 |
| 33289 | TRANSCATH IMPL WIRELESS PUL ART PRESS SENSOR W RT HEART CATH & ANGIO | $70,321 | $56,257 | — | — | 3 |
| 33249 | INSERT DEFIB SYSTEM W LEAD(S) SGL DUAL CHAMBER | $69,721 | $55,777 | — | — | 3 |
| 33264 | RMVL & REPLC DEFIB GEN MULT LEADS | $69,721 | $55,777 | — | — | 3 |
| C1763 | GRAFT MTX GENTRIX THICK30*NLU* | $67,896 | $54,317 | — | — | 4 |
| 33270 | SURG 33270 INSERT/RPLCMNT PERM SUBQ IMPLTBL DFB W/SUBQ ELTRD | $66,533 | $53,226 | — | — | 3 |
| J9229 | Inotuzumab Ozogamicin For IV Soln 0.9 MG | $64,353 | $51,483 | — | — | 3 |
| L8614 | COCHLEAR NUCLEUS CI512 | $63,595 | $50,876 | — | — | 3 |
| 33231 | INSERT DEFIB GENERATOR W EXIST MULT LEADS | $62,736 | $50,189 | — | — | 3 |
| J2351 | Ocrelizumab-Hyaluronidase-ocsq Inj 920-23000 MG-UNIT/23ML | $61,732 | $49,386 | — | — | 3 |
| J2507 | Pegloticase Inj 8 MG/ML (For IV Infusion) | $61,419 | $49,135 | — | — | 3 |
| J0638 | Canakinumab Subcutaneous Inj 150 MG/ML | $60,505 | $48,404 | — | — | 3 |
| J2350 | Ocrelizumab Soln For IV Infusion 300 MG/10ML | $59,004 | $47,203 | — | — | 3 |
| C1820 | STIM DBS ACTIVA RC RECHG | $57,500 | $46,000 | — | — | 2 |
| J9266 | Pegaspargase Inj 750 Unit/ML | $56,054 | $44,843 | — | — | 3 |
| 93656 | COMPRE EP EVAL ABLTJ ATR FIB PULM VEIN ISOLATION | $52,975 | $42,380 | — | — | 3 |
| C9293 | Glucarpidase For IV Inj 1000 UNIT | $52,505 | $42,004 | — | — | 2 |
| C2624 | KT PA CARDIOMEM SENSOR DEL SYS | $51,750 | $41,400 | — | — | 2 |
| 33263 | RMVL & REPLC DEFIB GEN DUAL LEADS | $50,148 | $40,118 | — | — | 3 |
| C1822 | SYS STIM SPNL SENZA IPG | $49,942 | $39,954 | — | — | 2 |
| 36906 | SURG 36906 THROMBECTOMY DIALYSIS CIRCUIT W STENT | $49,641 | $39,713 | — | — | 3 |
| 33240 | INSERT DEFIB GENERATOR W EXIST SNGLE LEAD | $49,378 | $39,502 | — | — | 3 |
| 93654 | COMPRE EP EVAL ABLTJ 3D MAPG TX VT | $48,286 | $38,629 | — | — | 3 |
| 33477 | SURG 33477 TRANSCATH PULM VALVE IMPL | $47,499 | $37,999 | — | — | 3 |
| 33262 | RMVL & REPLC DEFIB GEN SNGLE LEAD | $47,285 | $37,828 | — | — | 3 |
| C2616 | Y90 BRACYTX NONSTRANDED PER SOURCE | $46,759 | $37,407 | — | — | 3 |
| C1826 | STIM NEURO GENRTR INCEPTIV SCS | $46,000 | $36,800 | — | — | 2 |
| C9767 | REVASC LITHOTRIP-STENT-ATHER | $45,839 | $36,671 | — | — | 3 |
| 93653 | COMPRE EP EVAL ABLTJ 3D MAPG TX SVT | $45,322 | $36,258 | — | — | 3 |
| 33230 | INSERT DEFIB GENERATOR W EXIST DUAL LEADS | $45,123 | $36,098 | — | — | 3 |
| C9399 | Dinutuximab IV Soln 17.5 MG/5ML (3.5 MG/ML) | $44,803 | $35,842 | — | — | 2 |
| 37277 | SURG 37277 REVSC EVASC FPVT ST ATHRC UNI CPLX LES 1ST VSL | $44,439 | $35,551 | — | — | 2 |
| 0795T | TCAT INSJ PERM DUAL CHAMBER LDLS PM COMPL SYS | $44,125 | $35,300 | — | — | 3 |
| J9118 | Calaspargase Pegol-mknl IV Soln 3750 Unit/5ML (750 Unit/ML) | $43,704 | $34,963 | — | — | 3 |
| 37294 | SURG 37294 REVSC EVASC TPVT ST ATHRC UNI CPLX LES 1ST VSL | $43,258 | $34,606 | — | — | 2 |
| C2621 | BIV CONTAK RENEWAL TR*DISC* | $43,010 | $34,408 | — | — | 2 |
| J0202 | Alemtuzumab IV Inj 12 MG/1.2ML (10 MG/ML) | $41,773 | $33,419 | — | — | 3 |
| J9381 | Teplizumab-mzwv IV Soln 2 MG/2ML (1 MG/ML) | $41,700 | $33,360 | — | — | 3 |
| J1628 | Guselkumab IV Soln 200 MG/20ML (10 MG/ML) | $41,556 | $33,245 | — | — | 3 |
| C9775 | REVASC LITHOTRIP W STENT & ATHERECTOMY TIBIAL PERONEAL ARTERY | $40,901 | $32,721 | — | — | 3 |
| 37275 | SURG 37275 REVSC EVASC FPVT ST ATHRC UNI SF LES 1ST VSL | $40,439 | $32,351 | — | — | 2 |
| 37286 | SURG 37286 REVSC EVASC TPVT ST PLMT UNI CPLX LES 1ST VSL | $39,801 | $31,841 | — | — | 2 |
Showing top 50 of 13,855 priced procedures, sorted by gross charge.
Data straight from this hospital's federally-mandated machine-readable file (45 CFR § 180). The compliance grade reflects how completely the hospital published the six required data elements, not the quality of care.